EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeitOpen Access · CC BY 4.0

Late orbital radiotherapy combined with intravenous methylprednisolone in the management of long-lasting active graves’ orbitopathy: a case report and literature review

Martina Verrienti iD, Irene Gagliardi iD, Luisa Valente iD, Antonio Stefanelli, Luca Borgatti, Elena Franco, Manlio Galiè iD, Marta Bondanelli iD, Maria Chiara Zatelli iD, Maria Rosaria Ambrosio iD

Endocrine · 2024

DOI: 10.1007/s12020-024-03788-2 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Endocrine, 2024. Verfasst von Martina Verrienti und 9 weiteren Autor:innen. Beteiligte Einrichtung: Section of Endocrinology, Geriatrics & Internal Medicine, Department of Medical Sciences, University of Ferrara, Ferrara, Italy. Hauptthemen laut MEDLINE: Methylprednisolone, Graves Ophthalmopathy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Ferrara.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To present a case and review the literature on Orbital Radiotherapy (OR) combined with intravenous methylprednisolone, focusing on its late application in patients with long-lasting active Graves’ Orbitopathy (GO). Additionally, we suggest emerging perspective for future research in this context.

Method

Relevant literature (randomized controlled studies, retrospective studies and reviews) was explored on PubMed from January 1973 to January 2024, searching “orbital radiotherapy” & “Graves disease”.

Results

OR is a well-established second-line treatment for moderate-to-severe active GO, providing response rates comparable to glucocorticoids. Its anti-inflammatory effect makes OR particularly suitable for early active GO, and when combined with glucocorticoids, outcomes are synergistically improved. The emergence of the new Volumetric Modulated Arc Image-Guided Radiation Therapy (VMAT-IGRT) technique enables precise radiation delivery to the target, significantly reducing associated toxicity. This technological advancement enhances the feasibility of radiotherapy in benign diseases like GO. A retrospective study indicated that late OR in patients with long-lasting active GO may improve diplopia and visual acuity, decreasing disease activity. Our case report supports this conclusion.

Conclusions

This report and literature review underscores the importance of considering late OR combined with intravenous methylprednisolone as a viable treatment option for GO patients with prolonged disease activity, emphasizing the crucial role of personalized therapy in managing GO. However, further investigations are warranted to validate this approach in cases of long-lasting active GO.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethylprednisoloneGraves OphthalmopathyHumansFemaleCombined Modality TherapyAnti-Inflammatory AgentsTreatment OutcomeMiddle AgedGlucocorticoidsAdministration, Intravenous

Stichwörter der Autor:innen

Disease activityGraves’ orbitopathyIntravenous methylprednisoloneLate orbital radiotherapyVMAT-IGRT

Substanzen

MethylprednisoloneAnti-Inflammatory AgentsGlucocorticoids

Autor:innen und Institutionen

  • Section of Endocrinology, Geriatrics & Internal Medicine, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
  • Unit of Cranio Maxillo Facial Surgery, Center for Craniofacial Deformities & Orbital Surgery-Reference Center for Rare Disease, St. Anna University Hospital of Ferrara, Ferrara, Italy.
  • Department of Radiation Oncology, St. Anna University Hospital of Ferrara, Ferrara, Italy.
  • Neuroradiology Unit, Department of Neuroscience and Rehabilitation, St. Anna University Hospital of Ferrara, Ferrara, Italy.
  • Operational Unit of Ophthalmology, St. Anna University Hospital of Ferrara, Ferrara, Italy.
  • Section of Endocrinology, Geriatrics & Internal Medicine, Department of Medical Sciences, University of Ferrara, Ferrara, Italy. mbrmrs@unife.it.

ORCID-Profile: Martina Verrienti, Irene Gagliardi, Luisa Valente, Manlio Galiè, Marta Bondanelli, Maria Chiara Zatelli, Maria Rosaria Ambrosio

Förderung

  • Università degli Studi di Ferrara

Zitieren

APA

Verrienti, M., Gagliardi, I., Valente, L., Stefanelli, A., Borgatti, L., Franco, E., Galiè, M., Bondanelli, M., Zatelli, M. C., & Ambrosio, M. R. (2024). Late orbital radiotherapy combined with intravenous methylprednisolone in the management of long-lasting active graves’ orbitopathy: a case report and literature review. Endocrine. https://doi.org/10.1007/s12020-024-03788-2

Vancouver

Verrienti M, Gagliardi I, Valente L, Stefanelli A, Borgatti L, Franco E, et al. Late orbital radiotherapy combined with intravenous methylprednisolone in the management of long-lasting active graves’ orbitopathy: a case report and literature review. Endocrine. 2024. doi:10.1007/s12020-024-03788-2

BibTeX
@article{Verrienti2024,
  author = {Verrienti, Martina and Gagliardi, Irene and Valente, Luisa and Stefanelli, Antonio and Borgatti, Luca and Franco, Elena and Galiè, Manlio and Bondanelli, Marta and Zatelli, Maria Chiara and Ambrosio, Maria Rosaria},
  title = {Late orbital radiotherapy combined with intravenous methylprednisolone in the management of long-lasting active graves’ orbitopathy: a case report and literature review},
  journal = {Endocrine},
  year = {2024},
  doi = {10.1007/s12020-024-03788-2}
}
Kostenlos starten →